Farazi Fard, Mohammad Ali
Tabatabaei, Zahra
Ajam-Hosseini, Mobarakeh
Nikuei, Pooneh
Gila, Fatemeh
Parvini, Farshid https://orcid.org/0000-0002-8136-3254
Jamali, Payman
Article History
Received: 20 July 2025
Revised: 20 August 2025
Accepted: 22 August 2025
First Online: 1 September 2025
Competing interests
: The authors declare no competing interests.
: All methods were carried out in accordance with relevant guidelines and regulations. This study had been approved by the ethics committee of the pharmaceutical sciences branch of Islamic Azad University, Tehran, Iran (ethics approval code no. IR.IAU.PS.REC.1398.209). Written informed consent was obtained from parents and father of the patients, as their legal guardians, to participate in this study. A copy of the written consent is available as requested.